CLINICAL_TRIALS
trial_result
· 2017-07-12
Clinical Trial Update: Study of Molecular-targeted Therapy Using Zinc Finger Nuclease in Cervical Precancerous Lesions [Phase 1]
Summary
Phase 1 clinical trial evaluating molecular-targeted therapy using zinc finger nuclease for HPV-related cervical precancerous lesions. The study status is curre…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Huazhong University of Science and Technology | Conditions: Human Papillomavirus-Related Malignant Neoplasm | Phase 1 | Status: UNKNOWN